| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 3.16e-06 | 37 | 223 | 6 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 3.71e-06 | 38 | 223 | 6 | GO:0070001 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCC4 ABCA1 ABCA2 MYO10 DHX8 DDX10 ACSL4 STARD9 SHPRH DDX60L DNAH8 DYNC1H1 DNAH3 DHX57 CCT4 ZNFX1 NLRP10 ABCA6 ATP12A DNAH11 | 1.98e-05 | 614 | 223 | 20 | GO:0140657 |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 4.10e-05 | 18 | 223 | 4 | GO:0008569 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCC4 ABCA1 ABCA2 DHX8 DDX10 DDX60L DNAH8 DYNC1H1 DNAH3 DHX57 CCT4 NLRP10 ABCA6 ATP12A DNAH11 | 1.38e-04 | 441 | 223 | 15 | GO:0016887 |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 2.51e-04 | 28 | 223 | 4 | GO:0051959 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 3.64e-04 | 118 | 223 | 7 | GO:0003774 | |
| GeneOntologyCellularComponent | RNA N6-methyladenosine methyltransferase complex | 9.47e-05 | 9 | 222 | 3 | GO:0036396 | |
| GeneOntologyCellularComponent | hemidesmosome | 1.83e-04 | 11 | 222 | 3 | GO:0030056 | |
| GeneOntologyCellularComponent | paranodal junction | 1.83e-04 | 11 | 222 | 3 | GO:0033010 | |
| Domain | Spectrin_repeat | 8.04e-07 | 29 | 214 | 6 | IPR002017 | |
| Domain | SPEC | 1.49e-06 | 32 | 214 | 6 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 1.49e-06 | 32 | 214 | 6 | IPR018159 | |
| Domain | Spectrin | 5.36e-06 | 23 | 214 | 5 | PF00435 | |
| Domain | Dynein_heavy_chain_D4_dom | 1.53e-05 | 14 | 214 | 4 | IPR024317 | |
| Domain | Dynein_HC_stalk | 1.53e-05 | 14 | 214 | 4 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 1.53e-05 | 14 | 214 | 4 | IPR013602 | |
| Domain | DHC_N2 | 1.53e-05 | 14 | 214 | 4 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 1.53e-05 | 14 | 214 | 4 | IPR011704 | |
| Domain | MT | 1.53e-05 | 14 | 214 | 4 | PF12777 | |
| Domain | AAA_8 | 1.53e-05 | 14 | 214 | 4 | PF12780 | |
| Domain | AAA_5 | 1.53e-05 | 14 | 214 | 4 | PF07728 | |
| Domain | DHC_fam | 2.07e-05 | 15 | 214 | 4 | IPR026983 | |
| Domain | Dynein_heavy | 2.07e-05 | 15 | 214 | 4 | PF03028 | |
| Domain | Dynein_heavy_dom | 2.07e-05 | 15 | 214 | 4 | IPR004273 | |
| Domain | DHC_N1 | 7.96e-05 | 8 | 214 | 3 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 7.96e-05 | 8 | 214 | 3 | IPR013594 | |
| Domain | CH | 9.92e-05 | 65 | 214 | 6 | SM00033 | |
| Domain | P-loop_NTPase | ABCC4 ABCA1 ABCA2 MYO10 SLFN5 DHX8 DDX10 STARD9 ASPM SHPRH DDX60L DNAH8 DYNC1H1 DNAH3 GAL3ST1 DHX57 ZNFX1 ARF6 NLRP10 ABCA6 NLRP4 MYO16 DNAH11 | 1.17e-04 | 848 | 214 | 23 | IPR027417 |
| Domain | ACTININ_2 | 1.25e-04 | 23 | 214 | 4 | PS00020 | |
| Domain | ACTININ_1 | 1.25e-04 | 23 | 214 | 4 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 1.25e-04 | 23 | 214 | 4 | IPR001589 | |
| Domain | RNaseH-like_dom | 1.39e-04 | 69 | 214 | 6 | IPR012337 | |
| Domain | CH | 1.50e-04 | 70 | 214 | 6 | PF00307 | |
| Domain | - | 1.62e-04 | 71 | 214 | 6 | 1.10.418.10 | |
| Domain | CH | 1.90e-04 | 73 | 214 | 6 | PS50021 | |
| Domain | CH-domain | 2.20e-04 | 75 | 214 | 6 | IPR001715 | |
| Domain | AAA | 2.59e-04 | 144 | 214 | 8 | SM00382 | |
| Domain | AAA+_ATPase | 2.59e-04 | 144 | 214 | 8 | IPR003593 | |
| Domain | ABC_A | 3.02e-04 | 12 | 214 | 3 | IPR026082 | |
| Domain | PH | MYO10 SPTBN2 PLEKHM1 PLCL2 OSBP2 PLCG1 ACAP3 KALRN PREX2 OSBPL3 ARHGAP12 | 3.78e-04 | 278 | 214 | 11 | SM00233 |
| Domain | POU_dom_5 | 3.89e-04 | 3 | 214 | 2 | IPR015585 | |
| Domain | PH_DOMAIN | MYO10 SPTBN2 PLEKHM1 PLCL2 OSBP2 PLCG1 ACAP3 KALRN PREX2 OSBPL3 ARHGAP12 | 3.90e-04 | 279 | 214 | 11 | PS50003 |
| Domain | PH_domain | MYO10 SPTBN2 PLEKHM1 PLCL2 OSBP2 PLCG1 ACAP3 KALRN PREX2 OSBPL3 ARHGAP12 | 4.01e-04 | 280 | 214 | 11 | IPR001849 |
| Domain | PH_dom-like | MYO10 SPTBN2 PLEKHM1 JAK2 PTPN13 PLCL2 OSBP2 PLCG1 ACAP3 KALRN PREX2 FRMD4A OSBPL3 ARHGAP12 | 4.18e-04 | 426 | 214 | 14 | IPR011993 |
| Domain | - | MYO10 SPTBN2 PLEKHM1 PTPN13 PLCL2 OSBP2 PLCG1 ACAP3 KALRN PREX2 FRMD4A OSBPL3 ARHGAP12 | 6.01e-04 | 391 | 214 | 13 | 2.30.29.30 |
| Domain | SH3_1 | 6.18e-04 | 164 | 214 | 8 | PF00018 | |
| Domain | CaMKII_AD | 7.72e-04 | 4 | 214 | 2 | PF08332 | |
| Domain | Ca/CaM-dep_prot_kinase-assoc | 7.72e-04 | 4 | 214 | 2 | IPR013543 | |
| Domain | SH3 | 8.89e-04 | 216 | 214 | 9 | PS50002 | |
| Domain | SH3_domain | 1.01e-03 | 220 | 214 | 9 | IPR001452 | |
| Domain | Sortilin_C | 1.28e-03 | 5 | 214 | 2 | PF15901 | |
| Domain | Sortilin-Vps10 | 1.28e-03 | 5 | 214 | 2 | PF15902 | |
| Domain | VPS10 | 1.28e-03 | 5 | 214 | 2 | IPR006581 | |
| Domain | Sortilin_N | 1.28e-03 | 5 | 214 | 2 | IPR031778 | |
| Domain | Sortilin_C | 1.28e-03 | 5 | 214 | 2 | IPR031777 | |
| Domain | VPS10 | 1.28e-03 | 5 | 214 | 2 | SM00602 | |
| Domain | DMAP_binding | 1.28e-03 | 5 | 214 | 2 | PF06464 | |
| Domain | PH | 1.34e-03 | 229 | 214 | 9 | PF00169 | |
| Domain | Kinase-like_dom | CDK17 PRDM2 MAP3K5 JAK2 PTPN13 DST MYLK3 PIK3C2B KALRN CAMK2A CAMK2D TEX14 LIMK2 EIF2AK4 MAPK13 | 1.51e-03 | 542 | 214 | 15 | IPR011009 |
| Pubmed | BIRC6 ERBIN ADCY9 SEC24D PTPN13 DST UBR5 VPS13A GCC1 DYNC1H1 CDON DNMT1 SMAP1 EFCAB6 CNTRL CCT4 APOB AP3B1 ARF6 DENND6A IGF2R YKT6 USO1 GCC2 AKAP1 RPL3 | 8.61e-12 | 777 | 224 | 26 | 35844135 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | DNAJA2 BIRC6 DHX8 FANCD2 UBR5 PLCG1 DNAH8 DYNC1H1 DNMT1 POLR1A SLC25A4 SLC25A5 RBBP5 POLA1 NOL11 CCT4 AP3B1 PRPF8 VIRMA SACM1L ARF6 USO1 PRIM2 | 2.35e-10 | 704 | 224 | 23 | 29955894 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | SPTAN1 DNAJA2 BIRC6 NSUN2 ERBIN DDX10 ACSL4 DST PLAA UBR5 CLIC1 ASPM DDX60L PLCG1 PLEC DYNC1H1 DNMT1 POLR1A SLC25A5 GPX8 POLA1 CAMK2D NOL11 DHX57 CCT4 PRPF8 NGDN PRPF3 PRIM2 ATIC PIP4K2C RPL3 | 2.37e-10 | 1353 | 224 | 32 | 29467282 |
| Pubmed | ZC3H13 SPTAN1 ZZEF1 DST PLEC DNAH8 CCDC73 SLC25A4 SLC25A5 CCT4 ZFC3H1 ANKRD36B CROCC | 3.09e-10 | 187 | 224 | 13 | 26460568 | |
| Pubmed | ZC3H13 SPTAN1 SPTBN2 BIRC6 NSUN2 DHX8 DDX10 DST UBR5 PLEC DYNC1H1 DNMT1 POLR1A POLA1 NOL11 DHX57 PRPF8 VIRMA UBE2O IGF2R ATIC RPL3 | 3.34e-10 | 653 | 224 | 22 | 22586326 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | ZC3H13 SPTBN2 ZBTB41 SLFN5 ZZEF1 BIRC6 PRDM2 JAK2 DST VPS13A DYNC1H1 DNAH3 CCDC73 SLC25A5 RBBP5 POLA1 PRPF8 OTC DENND6A LOXHD1 P4HA1 DUSP16 ATIC | 5.55e-10 | 736 | 224 | 23 | 29676528 |
| Pubmed | 8.09e-09 | 12 | 224 | 5 | 14557543 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | SPTAN1 DNAJA2 NSUN2 PRDM2 DHX8 DDX10 FANCD2 CLIC1 STARD9 RBM15B PLCG1 TDRD6 DYNC1H1 DNMT1 POLR1A SLC25A5 RBBP5 POLA1 NOL11 CCT4 UFL1 APOB AP3B1 PRPF8 SACM1L UBE2O IGF2R USO1 ATIC RPL3 | 1.31e-08 | 1425 | 224 | 30 | 30948266 |
| Pubmed | CDK17 SPTAN1 DNAJA2 SPTBN2 ACTN2 ERBIN DST PLEC DAGLA DYNC1H1 TRIM46 SMAP1 SLC25A4 SLC25A5 KALRN CAMK2A CAMK2D DHX57 CCT4 ZNFX1 AP3B1 VIRMA SACM1L UBE2O USO1 ELAVL3 PIP4K2C CROCC RPL3 DNAH11 | 1.44e-08 | 1431 | 224 | 30 | 37142655 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ABCA2 MYO10 ZZEF1 PLXNB2 BIRC6 REXO1 PLEKHM1 ADCY9 MAP3K5 JAK2 SNX30 DST SH3TC1 PIK3C2B PLCG1 PLEC TAGLN DYNC1H1 BAHCC1 FRAS1 OFD1 KALRN CTC1 VPS39 IGF2R DUSP16 | 1.48e-08 | 1105 | 224 | 26 | 35748872 |
| Pubmed | SPTAN1 SPTBN2 ZBTB41 ACTN2 ERBIN ACSL4 DST STARD9 VPS13A RETREG1 ASPM PLEC DNAH8 BAHCC1 SLC25A4 SLC25A5 PCDHGB5 CNTRL DHX57 CCT4 APOB ZFC3H1 TEX14 PRPF8 NGDN ARHGAP12 EIF2AK4 NOSTRIN ATP12A RPL3 | 1.70e-08 | 1442 | 224 | 30 | 35575683 | |
| Pubmed | ELAPOR2 SPTAN1 DNAJA2 PRDM2 PTPN13 DST TDRD6 PLEC DYNC1H1 POLA1 CAMK2D OSBPL3 PRIM2 | 4.74e-08 | 284 | 224 | 13 | 29459677 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | DNAJA2 PLXNB2 NSUN2 DDX10 FANCD2 SLIT2 PLAA UBR5 FAM20B TARBP1 DYNC1H1 DNMT1 POLR1A GPX8 CAMK2D UFL1 AP3B1 SACM1L UBE2O IGF2R USO1 P4HA1 ATIC | 5.48e-08 | 942 | 224 | 23 | 31073040 |
| Pubmed | SPTAN1 DNAJA2 SPTBN2 ERBIN MAP3K5 DST UBR5 RABGEF1 DYNC1H1 DNMT1 TRIM46 DIP2B KALRN CAMK2A CAMK2D CCT4 ZNFX1 VIRMA UBE2O IGF2R OSBPL3 ELAVL3 PIP4K2C | 8.13e-08 | 963 | 224 | 23 | 28671696 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | DDX10 TXNRD1 FANCD2 PTPN13 PLAA UBR5 GCC1 DNMT1 OFD1 VPS39 POLA1 CNTRL AP3B1 ARF6 NGDN SEPSECS IGF2R P4HA1 GCC2 PRIM2 | 1.14e-07 | 754 | 224 | 20 | 33060197 |
| Pubmed | CDK17 ZC3H13 SPTAN1 DNAJA2 SPTBN2 PLXNB2 ERBIN ADCY9 DDX10 PTPN13 UBR5 VPS13A RETREG1 ASPM DNMT1 FRAS1 FAM184A OFD1 NOL11 UFL1 ZFC3H1 AP3B1 PRPF8 UBE2O IGF2R YKT6 P4HA1 AKAP1 RPL3 | 1.19e-07 | 1487 | 224 | 29 | 33957083 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CDK17 SPTAN1 ERBIN PTPN13 DST MYLK3 PIK3C2B STARD9 RABGEF1 PLEC DNMT1 DIP2B OFD1 CAMK2A CAMK2D VIRMA LIMK2 USO1 OSBPL3 AKAP1 GARRE1 | 2.18e-07 | 861 | 224 | 21 | 36931259 |
| Pubmed | Oct4 regulates DNA methyltransferase 1 transcription by direct binding of the regulatory element. | 2.64e-07 | 3 | 224 | 3 | 30140294 | |
| Pubmed | 2.64e-07 | 3 | 224 | 3 | 19932097 | ||
| Pubmed | 2.64e-07 | 3 | 224 | 3 | 14761969 | ||
| Pubmed | 2.64e-07 | 3 | 224 | 3 | 15978570 | ||
| Pubmed | 2.64e-07 | 3 | 224 | 3 | 16793732 | ||
| Pubmed | Regulation of lineage specific DNA hypomethylation in mouse trophectoderm. | 3.41e-07 | 10 | 224 | 4 | 23825703 | |
| Pubmed | ASXL1 MYO10 ERBIN UBR5 STARD9 PLCL2 DYNC1H1 FRAS1 CAMK2A VIRMA SACM1L GCC2 LRRTM2 CROCC | 4.75e-07 | 407 | 224 | 14 | 12693553 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | SPTAN1 CFB MAP3K5 SLIT2 DNMT1 DIP2B KALRN CAMK2D DHX57 UFL1 PREX2 INTS6 ARHGAP12 ELAVL3 RPL3 | 5.42e-07 | 475 | 224 | 15 | 31040226 |
| Pubmed | A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. | DDX10 GCC1 DNMT1 VPS39 POLA1 CNTRL AP3B1 ARF6 NGDN SEPSECS GCC2 PRIM2 | 6.17e-07 | 298 | 224 | 12 | 32353859 |
| Pubmed | ZC3H13 ZBTB41 ERBIN PRDM2 PTPN13 PLAA PLCL2 FAM20B PLCG1 PLEC CTC1 VPS39 CAMK2D CNTRL NOL11 APOB AP3B1 SEPSECS IGF2R OSBPL3 TMPRSS2 EIF2AK4 NLRP4 | 6.44e-07 | 1084 | 224 | 23 | 11544199 | |
| Pubmed | SPTAN1 SPTBN2 ERBIN MAP3K5 UBR5 DYNC1H1 DIP2B KALRN CAMK2A CAMK2D UBE2O | 8.01e-07 | 251 | 224 | 11 | 27507650 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | SPTBN2 PLXNB2 NSUN2 DHX8 DDX10 SLIT2 DST UBR5 CLIC1 PLEC DYNC1H1 POLR1A OFD1 SLC25A5 NOL11 CCT4 UFL1 PRPF8 IGF2R PRPF3 ATIC RPL3 | 9.32e-07 | 1024 | 224 | 22 | 24711643 |
| Pubmed | SPTAN1 SPTBN2 NSUN2 DDX10 ACSL4 CLIC1 STARD9 RBM15B PLEC DYNC1H1 DNMT1 SLC25A5 NOL11 DHX57 APOB AP3B1 PRPF8 VIRMA ARF6 NGDN ANKRD36B USO1 P4HA1 OSBPL3 EIF2AK4 NOSTRIN | 9.56e-07 | 1371 | 224 | 26 | 36244648 | |
| Pubmed | SPTAN1 DNAJA2 NSUN2 ACSL4 DDX60L PLEC DYNC1H1 DNMT1 SLC25A4 SLC25A5 RBBP5 NOL11 CCT4 UFL1 ZNFX1 PRPF8 UBE2O RPL3 | 9.80e-07 | 711 | 224 | 18 | 33022573 | |
| Pubmed | ABCA1 PLXNB2 PLEKHM1 CFB SHPRH DAGLA BAHCC1 CAMK2D PRPF8 FRMD4A IGF2R CNTNAP2 PIP4K2C | 1.00e-06 | 371 | 224 | 13 | 15747579 | |
| Pubmed | 1.05e-06 | 4 | 224 | 3 | 7945330 | ||
| Pubmed | 1.05e-06 | 4 | 224 | 3 | 16354795 | ||
| Pubmed | SPTAN1 DNAJA2 SPTBN2 BIRC6 ERBIN ADCY9 FANCD2 ACSL4 PTPN13 PLCL2 VPS13A DNMT1 OFD1 SLC25A5 CCT4 AP3B1 IGF2R P4HA1 PRPF3 PRIM2 DUSP16 EIF2AK4 | 1.38e-06 | 1049 | 224 | 22 | 27880917 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | ABCA2 SPTAN1 DNAJA2 ZZEF1 NSUN2 TXNRD1 DST CLIC1 PLEC DYNC1H1 RIC3 SLC25A5 CNTRL CCT4 AP3B1 PRPF8 ATIC RPL3 MYO16 | 1.42e-06 | 807 | 224 | 19 | 30575818 |
| Pubmed | 1.59e-06 | 14 | 224 | 4 | 9373155 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | SPTAN1 DNAJA2 BIRC6 NSUN2 DHX8 TXNRD1 UBR5 CLIC1 PLEC TARBP1 DYNC1H1 DNMT1 SMAP1 SLC25A4 SLC25A5 POLA1 CCT4 UFL1 AP3B1 PRPF8 UBE2O USO1 PRPF3 PRIM2 PIP4K2C RPL3 | 1.71e-06 | 1415 | 224 | 26 | 28515276 |
| Pubmed | 2.16e-06 | 130 | 224 | 8 | 12421765 | ||
| Pubmed | ABCC4 ABCA2 BIRC6 ACSL4 UBR5 CLIC1 DYNC1H1 DIP2B OFD1 SLC25A5 CAMK2D CNTRL AP3B1 PRPF8 ARF6 IGF2R USO1 P4HA1 PLXNC1 OSBPL3 GCC2 ATIC AKAP1 | 2.27e-06 | 1168 | 224 | 23 | 19946888 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | ZC3H13 SPTAN1 DNAJA2 SPTBN2 NSUN2 DHX8 DST CLIC1 RBM15B PLEC DYNC1H1 DNMT1 SLC25A5 DSG3 CAMK2D PARP2 NOL11 CCT4 ZFC3H1 PRPF8 VIRMA NGDN PRPF3 RPL3 | 2.30e-06 | 1257 | 224 | 24 | 36526897 |
| Pubmed | 2.30e-06 | 92 | 224 | 7 | 37343697 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | DNAJA2 BIRC6 NSUN2 DHX8 DDX10 ASPM RBM15B DNMT1 POLR1A SLC25A4 NOL11 DHX57 ZFC3H1 PRPF8 VIRMA NGDN PRPF3 AKAP1 | 2.45e-06 | 759 | 224 | 18 | 35915203 |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 2.61e-06 | 5 | 224 | 3 | 12629516 | |
| Pubmed | 2.61e-06 | 5 | 224 | 3 | 23554223 | ||
| Pubmed | 2.61e-06 | 5 | 224 | 3 | 21477851 | ||
| Pubmed | 2.61e-06 | 5 | 224 | 3 | 25238487 | ||
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | DNAJA2 NSUN2 ACSL4 SLIT2 DNMT1 SLC25A4 SLC25A5 CTC1 PARP2 DHX57 ZFC3H1 PRPF8 PRPF3 RPL3 | 3.78e-06 | 486 | 224 | 14 | 30940648 |
| Pubmed | SPTAN1 DNAJA2 PLEC DYNC1H1 SLC25A5 POLA1 NOL11 CCT4 UFL1 AP3B1 PRPF8 UBE2O YKT6 USO1 PRIM2 RPL3 | 4.49e-06 | 638 | 224 | 16 | 33239621 | |
| Pubmed | 5.20e-06 | 6 | 224 | 3 | 15063128 | ||
| Pubmed | 5.20e-06 | 6 | 224 | 3 | 16120608 | ||
| Pubmed | 5.20e-06 | 6 | 224 | 3 | 8452933 | ||
| Pubmed | 5.20e-06 | 6 | 224 | 3 | 22795133 | ||
| Pubmed | Spectrins and ankyrinB constitute a specialized paranodal cytoskeleton. | 5.20e-06 | 6 | 224 | 3 | 16687515 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | SPTAN1 DNAJA2 DHX8 DDX10 SLIT2 PTPN13 PLEC TAGLN POLR1A POLA1 CAMK2D NOL11 DHX57 ZFC3H1 AP3B1 PRPF8 NGDN | 5.36e-06 | 724 | 224 | 17 | 36232890 |
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | DNAJA2 PLXNB2 NSUN2 ERBIN FANCD2 UBR5 DYNC1H1 RBBP5 CCT4 PRPF8 INTS6 P4HA1 DUSP16 INTS9 RPL3 | 5.40e-06 | 573 | 224 | 15 | 28330616 |
| Pubmed | ZZEF1 NSUN2 DST DNMT1 DIP2B FRAS1 SLC25A4 RBBP5 DHX57 ZNFX1 AP3B1 SACM1L OSBPL3 EIF2AK4 RPL3 GARRE1 | 5.68e-06 | 650 | 224 | 16 | 38777146 | |
| Pubmed | NSUN2 ACSL4 PLEC DYNC1H1 SLC25A5 CAMK2D CCT4 IGF2R USO1 GCC2 RPL3 | 6.51e-06 | 312 | 224 | 11 | 37120454 | |
| Pubmed | 7.48e-06 | 20 | 224 | 4 | 33397958 | ||
| Pubmed | Functional specialization of beta-arrestin interactions revealed by proteomic analysis. | SPTAN1 NSUN2 SAG UBR5 CLIC1 DYNC1H1 DNAH3 POLR1A CAMK2D EIF2AK4 RPL3 | 7.56e-06 | 317 | 224 | 11 | 17620599 |
| Pubmed | DNAJA2 CLIC1 PLEC DNMT1 SLC25A5 MTF2 CAMK2D CCT4 PRPF8 P4HA1 | 7.82e-06 | 259 | 224 | 10 | 31162944 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | ZC3H13 SPTAN1 SPTBN2 DHX8 PTPN13 DST RBM15B PLEC DYNC1H1 DIP2B SLC25A4 SLC25A5 KALRN DHX57 UFL1 PRPF8 SACM1L INTS6 P4HA1 PRPF3 ELAVL3 | 7.97e-06 | 1082 | 224 | 21 | 38697112 |
| Pubmed | Mouse TEX14 is required for embryonic germ cell intercellular bridges but not female fertility. | 9.05e-06 | 7 | 224 | 3 | 19020301 | |
| Pubmed | 9.05e-06 | 7 | 224 | 3 | 9256245 | ||
| Pubmed | Stage-Specific Demethylation in Primordial Germ Cells Safeguards against Precocious Differentiation. | 9.05e-06 | 7 | 224 | 3 | 27618282 | |
| Pubmed | 9.05e-06 | 7 | 224 | 3 | 11839785 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | ASXL1 MYO10 DHX8 DDX10 UBR5 SHPRH PLEC TARBP1 DNMT1 POLR1A POLA1 CAMK2D PRPF8 UBE2O IGF2R PRPF3 GCC2 PRIM2 EIF2AK4 AKAP1 | 9.20e-06 | 1005 | 224 | 20 | 19615732 |
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 1.34e-05 | 120 | 224 | 7 | 31413325 | |
| Pubmed | ERBIN DHX8 DDX10 PTPN13 DST CLIC1 RBM15B FAM184A POLR1A NEBL RBBP5 PARP2 NOL11 DHX57 CCT4 UFL1 ZFC3H1 AP3B1 VIRMA NGDN INTS6 P4HA1 INTS9 CROCC AKAP1 | 1.41e-05 | 1497 | 224 | 25 | 31527615 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | MYO10 SPTAN1 SPTBN2 NSUN2 DHX8 DDX10 DST PLEC DYNC1H1 POLR1A SLC25A5 PARP2 CCT4 APOB PRPF8 NGDN PRPF3 OSBPL3 RPL3 | 1.43e-05 | 949 | 224 | 19 | 36574265 |
| Pubmed | Polony analysis of gene expression in ES cells and blastocysts. | 1.44e-05 | 8 | 224 | 3 | 18073198 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | ZC3H13 SPTAN1 SPTBN2 DHX8 DST PLEC DYNC1H1 SLC25A5 CCT4 PRPF8 UBE2O ATIC PIWIL3 | 1.52e-05 | 477 | 224 | 13 | 31300519 |
| Pubmed | DNAJA2 DHX8 DDX10 SLIT2 HP DYNC1H1 POLR1A NOL11 DHX57 CCT4 PRPF8 NGDN RPL3 | 1.73e-05 | 483 | 224 | 13 | 36912080 | |
| Pubmed | BIRC6 PRDM2 PTPN13 DST UBR5 PLEC POU5F1 POU5F1B USO1 GCC2 AKAP1 ZMYM5 | 1.95e-05 | 418 | 224 | 12 | 34709266 | |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | ELAPOR2 ASXL1 MYO10 NCF2 PLXNB2 NSUN2 ADCY9 SOCS7 ACSL4 SAG VPS13A ASPM SLC25A29 MGAT4C VWA3A DIP2B NEBL SLC25A4 UFL1 VIRMA OSBPL3 TRAF3IP3 | 1.97e-05 | 1242 | 224 | 22 | 30973865 |
| Pubmed | Intercellular bridges coordinate the transition from pluripotency to meiosis in mouse fetal oocytes. | 2.15e-05 | 9 | 224 | 3 | 33827806 | |
| Pubmed | Origin of climbing fiber neurons and their developmental dependence on Ptf1a. | 2.15e-05 | 9 | 224 | 3 | 17928434 | |
| Pubmed | NR2B tyrosine phosphorylation modulates fear learning as well as amygdaloid synaptic plasticity. | 2.15e-05 | 9 | 224 | 3 | 16710293 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | ZC3H13 NSUN2 DHX8 DDX10 RBM15B DYNC1H1 NOL11 DHX57 ZNFX1 PRPF8 VIRMA NGDN UBE2O PRPF3 PTCD2 AKAP1 RPL3 | 2.16e-05 | 807 | 224 | 17 | 22681889 |
| Pubmed | DNAJA2 BIRC6 ERBIN ADCY9 DHX8 DNMT1 POLR1A NEBL UBE2O IGF2R YKT6 USO1 P4HA1 ATIC CROCC AKAP1 | 2.48e-05 | 733 | 224 | 16 | 34672954 | |
| Pubmed | ABCC4 PLEKHM1 ACSL4 SNX30 PTPN13 DST VPS13A RETREG1 GCC1 DHX57 IGF2R YKT6 AKAP1 | 2.69e-05 | 504 | 224 | 13 | 34432599 | |
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | MYO10 SPTAN1 DNAJA2 SPTBN2 NSUN2 ACSL4 CLIC1 TDRD6 PLEC DYNC1H1 SLC25A5 CCT4 ATIC RPL3 | 2.73e-05 | 580 | 224 | 14 | 35676659 |
| Pubmed | 3.06e-05 | 10 | 224 | 3 | 12970426 | ||
| Pubmed | Cdk12 is essential for embryonic development and the maintenance of genomic stability. | 3.06e-05 | 10 | 224 | 3 | 26658019 | |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | DNAJA2 ACTN2 ACSL4 PLAA CLIC1 DYNC1H1 DNMT1 SLC25A4 SLC25A5 CCT4 AP3B1 PRPF8 ARF6 USO1 P4HA1 | 3.07e-05 | 665 | 224 | 15 | 30457570 |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | INPP5D ACSL4 PLEC DYNC1H1 RBBP5 CAMK2D CCT4 VIRMA INTS6 USO1 TRAF3IP3 | 3.16e-05 | 370 | 224 | 11 | 22922362 |
| Pubmed | ABCA2 SPTAN1 DNAJA2 SPTBN2 NSUN2 PTPN13 DST RETREG1 PLCG1 PLEC TARBP1 DYNC1H1 DNMT1 KALRN VPS39 CAMK2A ZNFX1 ZFC3H1 PRPF8 UBE2O ATIC ZMYM5 | 3.29e-05 | 1285 | 224 | 22 | 35914814 | |
| Pubmed | ZZEF1 ERBIN SEC24D DST UBR5 PLCL2 RABGEF1 PLEC DYNC1H1 MTF2 ZNF510 LIMK2 MAPK13 ZMYM5 | 3.35e-05 | 591 | 224 | 14 | 15231748 | |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 3.39e-05 | 94 | 224 | 6 | 21542922 | |
| Pubmed | 3.39e-05 | 94 | 224 | 6 | 32062451 | ||
| Pubmed | DNAJA2 NSUN2 TXNRD1 FANCD2 UBR5 CLIC1 PLEC DNMT1 POLR1A RBBP5 POLA1 NOL11 CCT4 UFL1 PRPF8 VIRMA PRPF3 PRIM2 ATIC | 3.52e-05 | 1014 | 224 | 19 | 32416067 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | DNAJA2 ACSL4 SLIT2 KL PTPN13 HP CLIC1 MME DYNC1H1 NEBL KALRN DSG3 IGF2R ARSF TMPRSS2 ATIC PIP4K2C CROCC ENPEP | 3.62e-05 | 1016 | 224 | 19 | 19056867 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ZC3H13 DNAJA2 SLFN5 PRDM2 DHX8 DST RBM15B DNMT1 SLC25A4 SLC25A5 MTF2 RBBP5 PARP2 NOL11 ZFC3H1 PRPF8 NGDN INTS6 PRPF3 OSBPL3 INTS9 RPL3 | 3.65e-05 | 1294 | 224 | 22 | 30804502 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | ZC3H13 SPTAN1 SPTBN2 PLEC DYNC1H1 DNMT1 DNAH3 POLR1A SLC25A4 SLC25A5 GPX8 CAMK2D CCT4 AP3B1 PRPF8 PIP4K2C RPL3 | 3.96e-05 | 847 | 224 | 17 | 35235311 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | DNAJA2 ZZEF1 PLXNB2 BIRC6 ADCY9 FANCD2 ACSL4 DST MIPEP VPS13A RETREG1 DIP2B SLC25A4 SLC25A5 NOL11 DHX57 CCT4 UFL1 OTC YKT6 OSBPL3 ARHGAP12 AKAP1 RPL3 | 4.02e-05 | 1496 | 224 | 24 | 32877691 |
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 28988986 | ||
| Pubmed | Abnormal DNA methylation of the Oct-4 enhancer region in cloned mouse embryos. | 4.13e-05 | 2 | 224 | 2 | 18932201 | |
| Pubmed | SORCS1 and SORCS3 control energy balance and orexigenic peptide production. | 4.13e-05 | 2 | 224 | 2 | 29440124 | |
| Pubmed | 4.13e-05 | 2 | 224 | 2 | 21502535 | ||
| Pubmed | ABCA2 is a strong genetic risk factor for early-onset Alzheimer's disease. | 4.13e-05 | 2 | 224 | 2 | 15649702 | |
| Interaction | EED interactions | ASXL1 ZFP42 ZC3H13 SPTAN1 PLXNB2 BIRC6 NSUN2 PRDM2 DDX10 FANCD2 ACSL4 CLIC1 SHPRH RABGEF1 PLEC DYNC1H1 DNMT1 SLC25A4 SLC25A5 MTF2 VPS39 NOL11 CCT4 AP3B1 PRPF8 VIRMA ARF6 IGF2R YKT6 USO1 P4HA1 UNC45B ATIC PIP4K2C CROCC MDGA1 RPL3 | 5.65e-07 | 1445 | 215 | 37 | int:EED |
| Interaction | GAN interactions | ZC3H13 SPTAN1 ZZEF1 DST PLEC DNAH8 CCDC73 SLC25A4 SLC25A5 CCT4 ZFC3H1 VIRMA ANKRD36B CROCC | 6.03e-07 | 253 | 215 | 14 | int:GAN |
| Interaction | TEDC2 interactions | ELAPOR2 SPTAN1 DNAJA2 PTPN13 DST TDRD6 PLEC DYNC1H1 POLA1 CAMK2D OSBPL3 PRIM2 | 2.29e-06 | 206 | 215 | 12 | int:TEDC2 |
| Interaction | DNAJA2 interactions | ASXL1 DNAJA2 FANCD2 FANCB CTC1 CCT4 UFL1 ZNFX1 POU5F1 PRPF8 VIRMA ARF6 LIMK2 UBE2O DENND6A DUSP16 EIF2AK4 AKAP1 GARRE1 | 6.07e-06 | 542 | 215 | 19 | int:DNAJA2 |
| Interaction | SLC16A1 interactions | ASXL1 FANCD2 UBR5 MME CNTRL UFL1 VIRMA ARF6 NGDN UBE2O AKAP1 | 1.05e-05 | 200 | 215 | 11 | int:SLC16A1 |
| Interaction | PCNT interactions | SPTAN1 SPTBN2 DST PLEC FAM184A OFD1 SLC25A4 KALRN CNTRL VIRMA USO1 DUSP16 | 1.14e-05 | 241 | 215 | 12 | int:PCNT |
| Interaction | SIRT7 interactions | ZC3H13 SPTAN1 SPTBN2 BIRC6 NSUN2 DHX8 DDX10 DST UBR5 PLEC DYNC1H1 DNMT1 POLR1A POLA1 NOL11 DHX57 PRPF8 VIRMA UBE2O IGF2R ATIC RPL3 | 1.63e-05 | 744 | 215 | 22 | int:SIRT7 |
| Interaction | PHLPP2 interactions | 2.10e-05 | 32 | 215 | 5 | int:PHLPP2 | |
| Interaction | RNF123 interactions | ZC3H13 SPTBN2 ZBTB41 SLFN5 ZZEF1 BIRC6 PRDM2 JAK2 DST VPS13A DYNC1H1 DNAH3 CCDC73 SLC25A5 RBBP5 POLA1 PRPF8 OTC DENND6A LOXHD1 P4HA1 DUSP16 ATIC | 2.58e-05 | 824 | 215 | 23 | int:RNF123 |
| Interaction | CAV1 interactions | SPTAN1 SPTBN2 ERBIN ADCY9 FANCD2 JAK2 PTPN13 DST PLAA RABGEF1 GCC1 PLCG1 VIRMA ARF6 UBE2O IGF2R YKT6 USO1 ATIC AKAP1 GARRE1 | 3.39e-05 | 724 | 215 | 21 | int:CAV1 |
| Interaction | BAG2 interactions | ASXL1 MYO10 DNAJA2 PIWIL1 SLFN5 ERBIN FANCD2 SMAP1 OFD1 CAMK2A UFL1 ZNFX1 POU5F1 ZFC3H1 PRPF8 VIRMA LIMK2 TMPRSS2 AKAP1 | 4.09e-05 | 622 | 215 | 19 | int:BAG2 |
| Interaction | NOLC1 interactions | MYO10 SPTBN2 FANCD2 UBR5 MME POLR1A AP3B1 VIRMA UBE2O LOXHD1 BRF1 CNTNAP2 PIP4K2C | 4.95e-05 | 325 | 215 | 13 | int:NOLC1 |
| Interaction | ENO1 interactions | ASXL1 PIWIL1 SLFN5 PRDM2 DHX8 FANCD2 UBR5 CLIC1 VPS13A TAGLN DNAH8 DYNC1H1 DNMT1 POLR1A POLA1 UFL1 ZNFX1 PRPF8 VIRMA OSBPL3 | 6.59e-05 | 701 | 215 | 20 | int:ENO1 |
| Interaction | SUMO2 interactions | SPTAN1 NSUN2 FANCD2 DST PLEC DYNC1H1 DNMT1 ANKRD35 DIP2B KALRN POLA1 CCT4 PRPF8 BRF1 P4HA1 ATIC RPL3 ZMYM5 | 6.80e-05 | 591 | 215 | 18 | int:SUMO2 |
| Interaction | KALRN interactions | 7.61e-05 | 96 | 215 | 7 | int:KALRN | |
| Interaction | HSP90AA1 interactions | ASXL1 SPTAN1 DNAJA2 GC ERBIN CFB MAP3K5 FANCD2 JAK2 FHAD1 MYLK3 HP RABGEF1 DYNC1H1 SLC25A5 POLA1 CAMK2A CAMK2D UFL1 APOB PRPF8 VIRMA LIMK2 BRF1 P4HA1 UNC45B MAPK13 RPL3 NLRP4 | 8.01e-05 | 1263 | 215 | 29 | int:HSP90AA1 |
| Interaction | RAB11A interactions | SPTAN1 BIRC6 NSUN2 ERBIN ADCY9 FANCD2 DST TC2N VPS13A RETREG1 RABGEF1 MME PLCG1 SLC25A4 VIRMA ARF6 DENND6A IGF2R YKT6 USO1 GCC2 AKAP1 | 8.34e-05 | 830 | 215 | 22 | int:RAB11A |
| Interaction | SHANK3 interactions | SPTAN1 SPTBN2 ACTN2 MAP3K5 DYNC1H1 ANKRD35 SLC25A5 KALRN CAMK2A CAMK2D VIRMA IGF2R USO1 ARHGAP12 PIP4K2C RPL3 | 8.98e-05 | 496 | 215 | 16 | int:SHANK3 |
| Interaction | TOP3B interactions | ABCA2 MYO10 SPTAN1 DNAJA2 SPTBN2 ZZEF1 PLXNB2 BIRC6 REXO1 PLEKHM1 ADCY9 MAP3K5 JAK2 SNX30 DST SH3TC1 PIK3C2B PLCG1 PLEC TAGLN DYNC1H1 BAHCC1 FRAS1 OFD1 KALRN CTC1 VPS39 DHX57 APOB IGF2R P4HA1 DUSP16 | 9.07e-05 | 1470 | 215 | 32 | int:TOP3B |
| Interaction | TRIM28 interactions | ASXL1 ZFP42 SPTAN1 DNAJA2 BIRC6 DHX8 FANCD2 ZNF544 UBR5 PLCG1 DNAH8 DYNC1H1 DNMT1 POLR1A SLC25A4 SLC25A5 RBBP5 POLA1 PARP2 NOL11 CCT4 UFL1 POU5F1 AP3B1 PRPF8 VIRMA SACM1L ARF6 UBE2O ZNF33A USO1 PRIM2 | 9.54e-05 | 1474 | 215 | 32 | int:TRIM28 |
| Interaction | ZFPL1 interactions | SPTAN1 SPTBN2 ERBIN FANCD2 PTPN13 DST GCC1 IGF2R YKT6 USO1 OSBPL3 GCC2 TMPRSS2 ATP12A AKAP1 | 9.92e-05 | 448 | 215 | 15 | int:ZFPL1 |
| Cytoband | 10q23-q25 | 1.40e-04 | 4 | 223 | 2 | 10q23-q25 | |
| Cytoband | 13q12 | 2.12e-04 | 24 | 223 | 3 | 13q12 | |
| Cytoband | 1q25 | 2.71e-04 | 26 | 223 | 3 | 1q25 | |
| GeneFamily | ATP binding cassette subfamily A | 1.83e-04 | 14 | 148 | 3 | 805 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.99e-04 | 206 | 148 | 8 | 682 | |
| GeneFamily | Dyneins, axonemal | 3.36e-04 | 17 | 148 | 3 | 536 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 7.41e-04 | 50 | 148 | 4 | 1293 | |
| GeneFamily | EF-hand domain containing|Spectrins | 1.36e-03 | 7 | 148 | 2 | 1113 | |
| GeneFamily | EF-hand domain containing|Plakins | 1.80e-03 | 8 | 148 | 2 | 939 | |
| GeneFamily | Argonaute/PIWI family | 1.80e-03 | 8 | 148 | 2 | 408 | |
| GeneFamily | Plexins | 2.31e-03 | 9 | 148 | 2 | 683 | |
| GeneFamily | Synaptotagmin like tandem C2 proteins | 2.87e-03 | 10 | 148 | 2 | 822 | |
| GeneFamily | Tudor domain containing | 3.41e-03 | 37 | 148 | 3 | 780 | |
| GeneFamily | Oxysterol binding proteins|Pleckstrin homology domain containing | 4.16e-03 | 12 | 148 | 2 | 670 | |
| Coexpression | NAKAYA_B_CELL_FLUMIST_AGE_18_50YO_7DY_UP | ABCA1 TXNRD1 SERPINB8 RBM15B PARP2 CCT4 ARF6 NGDN LIMK2 IGF2R OSBPL3 PRIM2 CNTNAP2 INTS9 MAPK13 AKAP1 GARRE1 ZMYM5 | 8.20e-08 | 475 | 214 | 18 | M40979 |
| Coexpression | GSE37301_PRO_BCELL_VS_RAG2_KO_NK_CELL_DN | ASXL1 ABCA2 INPP5D PTPN13 DST CAMK2D PARP2 IGF2R P4HA1 PLXNC1 OSBPL3 | 2.78e-07 | 179 | 214 | 11 | M8900 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | CDK17 ASXL1 MYO10 ZZEF1 ADCY9 DDX10 TXNRD1 ACSL4 SLIT2 SEC24D PTPN13 DST UBR5 DBF4 VPS13A MTF2 AP3B1 IGF2R GCC2 PRIM2 ARHGAP12 GARRE1 | 2.27e-06 | 856 | 214 | 22 | M4500 |
| Coexpression | GENTILE_UV_LOW_DOSE_DN | 1.40e-05 | 64 | 214 | 6 | M4594 | |
| Coexpression | HALLMARK_PROTEIN_SECRETION | 1.41e-05 | 96 | 214 | 7 | M5910 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | ABCC4 PLXNB2 ACSL4 SNX30 SEC24D PTPN13 TC2N MMP7 TEX14 AKAP1 | 2.05e-08 | 179 | 218 | 10 | fd2cbee532e7b44113410dca82aec7db1a7fb69f |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.66e-08 | 184 | 218 | 10 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | MYO10 SLIT2 DST VWA3A FRAS1 PREX2 PIEZO2 ABCA6 CNTNAP2 ENPEP | 3.43e-08 | 189 | 218 | 10 | 203c80030df08ae112f9ae4043709f455d87ce89 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.27e-07 | 184 | 218 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.27e-07 | 184 | 218 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.27e-07 | 184 | 218 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.59e-07 | 186 | 218 | 9 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.48e-07 | 191 | 218 | 9 | 08720998aa55131d7377c4c67c4c935865bd7d79 | |
| ToppCell | RA-09._Endothelium_I|World / Chamber and Cluster_Paper | CDK17 MYO10 ST8SIA6 PIK3C2B DOC2B KALRN PREX2 NOSTRIN GARRE1 | 4.48e-07 | 191 | 218 | 9 | c8a0c2af119bc34a8f694a7d30642f28002c84b9 |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.11e-07 | 194 | 218 | 9 | a3e5a15cf6c1361207f661ee15eb634f77daf1cb | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 5.33e-07 | 195 | 218 | 9 | 22191d361af136942508f1553ff41a626ed982ad | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | CDK17 INPP5D ST8SIA6 PIK3C2B STARD9 KALRN PREX2 NOSTRIN GARRE1 | 5.57e-07 | 196 | 218 | 9 | 145fcf73deba9638b391a1af6c39fa205dc9829f |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.81e-07 | 197 | 218 | 9 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.81e-07 | 197 | 218 | 9 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | healthy_donor-Lymphocytic-T_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 5.81e-07 | 197 | 218 | 9 | 63d0f06e150e7eb800ecb70e97b9d12a01c84e37 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.32e-07 | 199 | 218 | 9 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.32e-07 | 199 | 218 | 9 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.32e-07 | 199 | 218 | 9 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.59e-07 | 200 | 218 | 9 | e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 6.59e-07 | 200 | 218 | 9 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.59e-07 | 200 | 218 | 9 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.91e-06 | 169 | 218 | 8 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.70e-06 | 177 | 218 | 8 | 26bad614560609d318bfc9c235a698bca4e1c22c | |
| ToppCell | MatrixFB-Fibroblast-A|MatrixFB / shred on cell class and cell subclass (v4) | 3.05e-06 | 180 | 218 | 8 | adc64ad6033af705dd7b9163a83e20ef5c59f6eb | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.18e-06 | 181 | 218 | 8 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 3.18e-06 | 181 | 218 | 8 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.74e-06 | 185 | 218 | 8 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.74e-06 | 185 | 218 | 8 | a0a629e5d2b65f670ea907bd3f5e3caf17687d8f | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.89e-06 | 186 | 218 | 8 | 74c238759c5d3fd39127ec0060d0c2cb16b326d4 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.05e-06 | 187 | 218 | 8 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B0|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.05e-06 | 187 | 218 | 8 | 816d37a70f7ec382a268fe828b3dfe737a36a4bf | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.21e-06 | 188 | 218 | 8 | 58ccb31cdf43167872ef0fc737e6f9c51ee2e060 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 4.21e-06 | 188 | 218 | 8 | 14bc73cf79c79c9f208369fd8d498e5b26e0114d | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-Plasma_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.21e-06 | 188 | 218 | 8 | 34873972dff9284dfcd26bb698c9d1df007f1cbb | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 4.21e-06 | 188 | 218 | 8 | b070a0667f1ee9b825b267b6c389b7c42fc436f9 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.38e-06 | 189 | 218 | 8 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.73e-06 | 191 | 218 | 8 | 96b78b4e819ea6052334bfcbc7abbf35897df885 | |
| ToppCell | RA-09._Endothelium_I|RA / Chamber and Cluster_Paper | 4.92e-06 | 192 | 218 | 8 | 8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.92e-06 | 192 | 218 | 8 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.11e-06 | 193 | 218 | 8 | f4310faa13fc8ce99a217e2d1c9cc733683797a1 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.11e-06 | 193 | 218 | 8 | 089aece40130034a89a5213be778f10b0787eeba | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.11e-06 | 193 | 218 | 8 | 2901d7a9672a8cf70c9f1c752685b45e4d79ac70 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor | 5.11e-06 | 193 | 218 | 8 | 738f4f0a9ddde2432b429ab46838e353b1790589 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.11e-06 | 193 | 218 | 8 | f8af695457d2a0a911a5ac491742465864ebda37 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.11e-06 | 193 | 218 | 8 | 097a244cf37ce6c1ace9bae56beb7de59442cd6b | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.31e-06 | 194 | 218 | 8 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.31e-06 | 194 | 218 | 8 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.31e-06 | 194 | 218 | 8 | 1b382508453c5b08fb617f626b230adf3b6cff99 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 5.51e-06 | 195 | 218 | 8 | 4bdedd924564a260841a9153604026b57487c83d | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.51e-06 | 195 | 218 | 8 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.51e-06 | 195 | 218 | 8 | cd011433b3b9bfb1adb13eca2f3f2a5db024cd94 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.72e-06 | 196 | 218 | 8 | b8f89a50114932c08fc5daac4b549adfe9df8e66 | |
| ToppCell | Sepsis-URO-Lymphocyte-T/NK-Treg|URO / Disease, condition lineage and cell class | 5.72e-06 | 196 | 218 | 8 | 8812d7365fb2b33feff93782d60776e932499a43 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.72e-06 | 196 | 218 | 8 | d0ff1082898d2db47c88d2678466514e9e9193d3 | |
| ToppCell | COVID_non-vent-Lymphocytic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 5.94e-06 | 197 | 218 | 8 | c672915f8c8c1e948d251f6eaf9f84a5600c1193 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 5.94e-06 | 197 | 218 | 8 | 6b6504c47c309bac4f790e2f372d454bbdea49e8 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.94e-06 | 197 | 218 | 8 | bf10727fbe90b71d2ac60a11711e5f0701b3799d | |
| ToppCell | 343B-Epithelial_cells-Epithelial-B_(AT2)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.94e-06 | 197 | 218 | 8 | f98720cab066579fdac3ba24fb6fe4c5759dae4e | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-G|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.94e-06 | 197 | 218 | 8 | a21a710c824f9e5c7ef1674168d1ce5aef85bd35 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 5.94e-06 | 197 | 218 | 8 | 44a59dfb889577b3160a5b13ada1276771a00241 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.94e-06 | 197 | 218 | 8 | 1485933986921ff45669d9b7501c8d17050b3e97 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-B_(AT2)|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.94e-06 | 197 | 218 | 8 | f3ca63c7902d7530a29a85eb54f69b303031d150 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.94e-06 | 197 | 218 | 8 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_ciliated-Deuterosomal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.17e-06 | 198 | 218 | 8 | f31790442ef142f1c0c49bf3daf2d0efb193d2c9 | |
| ToppCell | COVID_vent-Lymphocytic-T_cell-CD4+_Memory_T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 6.17e-06 | 198 | 218 | 8 | 58f208b76cb0adcecdf632d92f92833a06f9bf71 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.17e-06 | 198 | 218 | 8 | 2e2a4e1756bba6f4fbe529559a97d2993c890b4b | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.17e-06 | 198 | 218 | 8 | 285f729140b1df029c24f6ca1d2438470ac51794 | |
| ToppCell | Sepsis-ICU-SEP-Lymphocyte-T/NK-MAIT|ICU-SEP / Disease, condition lineage and cell class | 6.40e-06 | 199 | 218 | 8 | 2f10622319c6146dfed8cfe3844180c1e1d56e94 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.64e-06 | 200 | 218 | 8 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.64e-06 | 200 | 218 | 8 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.64e-06 | 200 | 218 | 8 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.64e-06 | 200 | 218 | 8 | 44a68bacdb3d5bf563bd35952176995850933a81 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.64e-06 | 200 | 218 | 8 | dc61016c61729f69649cfb21f6264e685ce83dea | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 6.64e-06 | 200 | 218 | 8 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B0|367C / Donor, Lineage, Cell class and subclass (all cells) | 8.92e-06 | 149 | 218 | 7 | 41f28138bde45d0b814e116837e5a32b5e80d54a | |
| ToppCell | E16.5-samps-Myeloid-Fetal_macrophage-macrophage_-_intermediate_-_unactivated|E16.5-samps / Age Group, Lineage, Cell class and subclass | 9.32e-06 | 150 | 218 | 7 | 60fdd266aaca1b589b9a77465a4a7fad4921339a | |
| ToppCell | URO-Lymphocyte-T_NK-Treg|URO / Disease, Lineage and Cell Type | 1.11e-05 | 154 | 218 | 7 | 73fe0e26088a1b012902cc062ffbb3e4d2ff09f9 | |
| ToppCell | TCGA-Uterus-Primary_Tumor-Uterine_Carcinoma-Uterine_Carcinosarcoma-3|TCGA-Uterus / Sample_Type by Project: Shred V9 | 1.60e-05 | 163 | 218 | 7 | d64dd39b077105c73e570ccef70f0e74a2c586ac | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-MAIT|ICU-SEP / Disease, Lineage and Cell Type | 1.66e-05 | 164 | 218 | 7 | db863a44fc0dad5518c47fdbf64ea21d6f36f089 | |
| ToppCell | COVID-19-Heart-Neuronal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.94e-05 | 168 | 218 | 7 | 88c2c574f428c2502b5fe099bd73b0758f668ef6 | |
| ToppCell | MS-CD8-proli_CD4|MS / Condition, Cell_class and T cell subcluster | 2.26e-05 | 172 | 218 | 7 | 0b6dd257110b3f17fa71ab18a165b091a9d5ae9a | |
| ToppCell | PND01-03-samps-Endothelial-Postnatal_endothelial-endothelial_cells_D|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 2.44e-05 | 174 | 218 | 7 | b4f3f5334803e5903bc496decf923f2e44f7fa3c | |
| ToppCell | droplet-Marrow-nan-18m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-05 | 174 | 218 | 7 | 55cc8300489d11322724159ec7d0e1d32a702e91 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic-Neutrophil-Neu_c4-RSAD2|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.53e-05 | 175 | 218 | 7 | 97616bb5c127284aa9e67bc336dfcf29e137164b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.62e-05 | 176 | 218 | 7 | 25ebc8716aa44e44fce577701e3e82c6745a75ab | |
| ToppCell | droplet-Liver-Npc-18m-Lymphocytic-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-05 | 178 | 218 | 7 | 09d2687e0d79f12e90af35fc1c0453d249cf2d19 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.03e-05 | 180 | 218 | 7 | b798a3fa2dd15b68aa4267f665559527043dcc07 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-2|TCGA-Skin / Sample_Type by Project: Shred V9 | 3.13e-05 | 181 | 218 | 7 | 9d5b331cabc5524f0a9fd8b571e87be4c447c7d4 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 3.25e-05 | 182 | 218 | 7 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_T-T_NK-CD8_T_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.25e-05 | 182 | 218 | 7 | 98c26ad34e01c4b8997d26d5d28a9935491295fa | |
| ToppCell | LPS-IL1RA|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.48e-05 | 184 | 218 | 7 | c066c2ec4f0f1d6eb183fca5c7bb0cd45c9950dc | |
| ToppCell | Control-Epithelial_alveolar-AT_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.48e-05 | 184 | 218 | 7 | 51e129b3fcc2df083eda05a3afe3717218b1e52b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.48e-05 | 184 | 218 | 7 | 5350b58aa9979631228835d11eb45ddf81d08bff | |
| ToppCell | tumor_Lung-Fibroblasts-Mesothelial_cells|tumor_Lung / Location, Cell class and cell subclass | 3.48e-05 | 184 | 218 | 7 | b0a251030d127858e68cf164be158f209a4d720f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.73e-05 | 186 | 218 | 7 | a6ef5d5944af5689b5f27bef89cd05645eedbe50 | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 3.86e-05 | 187 | 218 | 7 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.86e-05 | 187 | 218 | 7 | f6217d0dd425eac76900b44a4e48f45475f3ac36 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.99e-05 | 188 | 218 | 7 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.99e-05 | 188 | 218 | 7 | e30a4ddac0da8cdcf621d98e28e3895cd9307e7a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.99e-05 | 188 | 218 | 7 | e751cff2ac8fbc1487766c1871fcc5d1005286b0 | |
| Disease | Colorectal Carcinoma | ABCC4 ABCA1 SPTBN2 TXNRD1 ACSL4 KL MYLK3 SH3TC1 VPS13A DNAH8 RIC3 DNAH3 KALRN APOB PREX2 BRF1 ABCA6 TRAF3IP3 | 3.65e-06 | 702 | 212 | 18 | C0009402 |
| Disease | beta thalassemia (is_marker_for) | 5.78e-05 | 11 | 212 | 3 | DOID:12241 (is_marker_for) | |
| Disease | hydroquinone sulfate measurement | 1.53e-04 | 3 | 212 | 2 | EFO_0021157 | |
| Disease | membranous glomerulonephritis (is_implicated_in) | 1.53e-04 | 3 | 212 | 2 | DOID:10976 (is_implicated_in) | |
| Disease | retinitis pigmentosa (is_implicated_in) | 2.13e-04 | 41 | 212 | 4 | DOID:10584 (is_implicated_in) | |
| Disease | obsolete_red blood cell distribution width | ASXL1 BIRC6 REXO1 ADCY9 ST8SIA6 PLCL2 VPS13A OSBP2 DAGLA DIP2B POLR1A KALRN RBBP5 APOB AP3B1 FRMD4A LIMK2 LOXHD1 ABCA6 EIF2AK4 GARRE1 MYO16 | 3.00e-04 | 1347 | 212 | 22 | EFO_0005192 |
| Disease | HSAN Type IV | 3.05e-04 | 4 | 212 | 2 | C0020074 | |
| Disease | myeloproliferative neoplasm (implicated_via_orthology) | 3.05e-04 | 4 | 212 | 2 | DOID:2226 (implicated_via_orthology) | |
| Disease | Hereditary Sensory Radicular Neuropathy | 3.05e-04 | 4 | 212 | 2 | C0086405 | |
| Disease | response to steroid, systemic lupus erythematosus, idiopathic osteonecrosis of the femoral head | 3.05e-04 | 4 | 212 | 2 | EFO_0020976, EFO_1001930, MONDO_0007915 | |
| Disease | autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 2 (implicated_via_orthology) | 3.05e-04 | 4 | 212 | 2 | DOID:0111517 (implicated_via_orthology) | |
| Disease | Hereditary Sensory and Autonomic Neuropathies | 3.05e-04 | 4 | 212 | 2 | C0027889 | |
| Disease | hereditary sensory neuropathy (implicated_via_orthology) | 5.07e-04 | 5 | 212 | 2 | DOID:0050548 (implicated_via_orthology) | |
| Disease | Hereditary Sensory Autonomic Neuropathy, Type 2 | 5.07e-04 | 5 | 212 | 2 | C0020072 | |
| Disease | Liver Cirrhosis, Experimental | ASPN INPP5D SPTAN1 GC JAK2 CLIC1 MME SLC25A4 GPX8 CAMK2D LIMK2 OTC IGF2R DUSP16 ENPEP | 5.14e-04 | 774 | 212 | 15 | C0023893 |
| Disease | total lipids in LDL measurement | 5.35e-04 | 52 | 212 | 4 | EFO_0022308 | |
| Disease | carnosine measurement | 6.62e-04 | 24 | 212 | 3 | EFO_0010470 | |
| Disease | Dyslipidemias | 6.62e-04 | 24 | 212 | 3 | C0242339 | |
| Disease | Dyslipoproteinemias | 6.62e-04 | 24 | 212 | 3 | C0598784 | |
| Disease | endometriosis (is_marker_for) | 7.48e-04 | 25 | 212 | 3 | DOID:289 (is_marker_for) | |
| Disease | Sensory Neuropathy, Hereditary | 7.56e-04 | 6 | 212 | 2 | C0699739 | |
| Disease | total lipids in large LDL | 7.59e-04 | 57 | 212 | 4 | EFO_0022163 | |
| Disease | cholesterol in large LDL measurement | 7.59e-04 | 57 | 212 | 4 | EFO_0021901 | |
| Disease | coronary artery disease (is_implicated_in) | 7.91e-04 | 100 | 212 | 5 | DOID:3393 (is_implicated_in) | |
| Disease | Alzheimer disease | APH1B ABCA1 INPP5D FANCD2 MME PLEC CDON FRMD4A CNTNAP2 CATSPERB MYO16 | 8.23e-04 | 485 | 212 | 11 | MONDO_0004975 |
| Disease | Acute monocytic leukemia | 8.42e-04 | 26 | 212 | 3 | C0023465 | |
| Disease | corpus callosum mid-anterior volume measurement | 9.42e-04 | 27 | 212 | 3 | EFO_0010297 | |
| Disease | Retinitis Pigmentosa | 9.44e-04 | 104 | 212 | 5 | C0035334 | |
| Disease | retinal degeneration (biomarker_via_orthology) | 1.05e-03 | 28 | 212 | 3 | DOID:8466 (biomarker_via_orthology) | |
| Disease | epidermolysis bullosa simplex (is_implicated_in) | 1.05e-03 | 7 | 212 | 2 | DOID:4644 (is_implicated_in) | |
| Disease | Hereditary Sensory Autonomic Neuropathy, Type 5 | 1.05e-03 | 7 | 212 | 2 | C0020075 | |
| Disease | hepatocellular carcinoma (biomarker_via_orthology) | 1.12e-03 | 108 | 212 | 5 | DOID:684 (biomarker_via_orthology) | |
| Disease | Miller Dieker syndrome | 1.16e-03 | 29 | 212 | 3 | C0265219 | |
| Disease | epilepsy (implicated_via_orthology) | 1.19e-03 | 163 | 212 | 6 | DOID:1826 (implicated_via_orthology) | |
| Disease | low density lipoprotein cholesterol measurement, physical activity | 1.32e-03 | 66 | 212 | 4 | EFO_0003940, EFO_0004611 | |
| Disease | MYELODYSPLASTIC SYNDROME | 1.39e-03 | 67 | 212 | 4 | C3463824 | |
| Disease | postherpetic neuralgia | 1.40e-03 | 8 | 212 | 2 | MONDO_0041052 | |
| Disease | myelofibrosis (is_implicated_in) | 1.40e-03 | 8 | 212 | 2 | DOID:4971 (is_implicated_in) | |
| Disease | Hereditary Sensory Autonomic Neuropathy, Type 1 | 1.40e-03 | 8 | 212 | 2 | C0020071 | |
| Disease | Drug habituation | 1.48e-03 | 115 | 212 | 5 | C0013170 | |
| Disease | Drug abuse | 1.48e-03 | 115 | 212 | 5 | C0013146 | |
| Disease | Prescription Drug Abuse | 1.48e-03 | 115 | 212 | 5 | C4316881 | |
| Disease | Substance-Related Disorders | 1.48e-03 | 115 | 212 | 5 | C0236969 | |
| Disease | Drug Use Disorders | 1.48e-03 | 115 | 212 | 5 | C0013222 | |
| Disease | Drug Dependence | 1.48e-03 | 115 | 212 | 5 | C1510472 | |
| Disease | antihyperlipidemic drug use measurement | 1.48e-03 | 115 | 212 | 5 | EFO_0803367 | |
| Disease | Substance Dependence | 1.48e-03 | 115 | 212 | 5 | C0038580 | |
| Disease | Substance Use Disorders | 1.48e-03 | 115 | 212 | 5 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 1.48e-03 | 115 | 212 | 5 | C0029231 | |
| Disease | Substance abuse problem | 1.54e-03 | 116 | 212 | 5 | C0740858 | |
| Disease | heart conduction disease (implicated_via_orthology) | 1.56e-03 | 32 | 212 | 3 | DOID:10273 (implicated_via_orthology) | |
| Disease | fatty liver disease (biomarker_via_orthology) | 1.70e-03 | 33 | 212 | 3 | DOID:9452 (biomarker_via_orthology) | |
| Disease | urate measurement, bone density | ERBIN CFB DDX10 MIPEP DNAH8 FRAS1 CAMK2D USO1 PLXNC1 EIF2AK4 MYO16 DNAH11 | 1.84e-03 | 619 | 212 | 12 | EFO_0003923, EFO_0004531 |
| Disease | Keloid | 2.02e-03 | 35 | 212 | 3 | C0022548 | |
| Disease | coronary aneurysm | 2.02e-03 | 35 | 212 | 3 | EFO_1000881 | |
| Disease | cardiovascular system disease (is_marker_for) | 2.23e-03 | 10 | 212 | 2 | DOID:1287 (is_marker_for) | |
| Disease | brain measurement, neuroimaging measurement | SLIT2 PLEC BAHCC1 DIP2B RBBP5 GAL3ST1 SACM1L PRPF3 CATSPERB NOSTRIN DNAH11 | 2.23e-03 | 550 | 212 | 11 | EFO_0004346, EFO_0004464 |
| Disease | linoleic acid measurement | 2.33e-03 | 186 | 212 | 6 | EFO_0006807 | |
| Disease | Bipolar Disorder | STARD9 PLCG1 DNAH8 DNMT1 VIP SLC25A4 CAMK2A CNTNAP2 PIP4K2C MDGA1 | 2.50e-03 | 477 | 212 | 10 | C0005586 |
| Disease | Cognition Disorders | 2.56e-03 | 38 | 212 | 3 | C0009241 | |
| Disease | response to radiation, breast carcinoma | 2.71e-03 | 11 | 212 | 2 | EFO_0000305, GO_0009314 | |
| Disease | neuroticism measurement, response to selective serotonin reuptake inhibitor | 2.71e-03 | 11 | 212 | 2 | EFO_0005658, EFO_0007660 | |
| Disease | Complications of Diabetes Mellitus | 2.71e-03 | 11 | 212 | 2 | C0342257 | |
| Disease | visual epilepsy (is_implicated_in) | 2.71e-03 | 11 | 212 | 2 | DOID:11832 (is_implicated_in) | |
| Disease | diabetes mellitus (is_marker_for) | 3.19e-03 | 41 | 212 | 3 | DOID:9351 (is_marker_for) | |
| Disease | Drug toxicity | 3.19e-03 | 84 | 212 | 4 | C0013221 | |
| Disease | Adverse reaction to drug | 3.19e-03 | 84 | 212 | 4 | C0041755 | |
| Disease | alpha-hydroxybutyric acid measurement | 3.23e-03 | 12 | 212 | 2 | EFO_0010458 | |
| Disease | Tumoral calcinosis | 3.42e-03 | 42 | 212 | 3 | C0263628 | |
| Disease | Calcinosis | 3.42e-03 | 42 | 212 | 3 | C0006663 | |
| Disease | Microcalcification | 3.42e-03 | 42 | 212 | 3 | C0521174 | |
| Disease | oral microbiome measurement | 3.42e-03 | 42 | 212 | 3 | EFO_0801229 | |
| Disease | triglycerides in large LDL measurement | 3.65e-03 | 43 | 212 | 3 | EFO_0022319 | |
| Disease | putamen volume change measurement | 3.80e-03 | 13 | 212 | 2 | EFO_0021495 | |
| Disease | pallidum volume change measurement | 3.80e-03 | 13 | 212 | 2 | EFO_0021494 | |
| Disease | Hyperlipoproteinemia Type IIb | 3.80e-03 | 13 | 212 | 2 | C1704417 | |
| Disease | Sclerocystic Ovaries | 3.92e-03 | 144 | 212 | 5 | C1136382 | |
| Disease | Polycystic Ovary Syndrome | 3.92e-03 | 144 | 212 | 5 | C0032460 | |
| Disease | obesity (biomarker_via_orthology) | 4.28e-03 | 147 | 212 | 5 | DOID:9970 (biomarker_via_orthology) | |
| Disease | Metabolic Bone Disorder | 4.42e-03 | 14 | 212 | 2 | C0005944 | |
| Disease | membranous glomerulonephritis (biomarker_via_orthology) | 4.42e-03 | 14 | 212 | 2 | DOID:10976 (biomarker_via_orthology) | |
| Disease | Fanconi anemia | 4.42e-03 | 14 | 212 | 2 | cv:C0015625 | |
| Disease | Kartagener syndrome (implicated_via_orthology) | 4.42e-03 | 14 | 212 | 2 | DOID:0050144 (implicated_via_orthology) | |
| Disease | pimelic acid measurement, 3-methyladipic acid measurement | 4.42e-03 | 14 | 212 | 2 | EFO_0010449, EFO_0010524 | |
| Disease | insulin metabolic clearance rate measurement, glucose homeostasis measurement | 4.42e-03 | 14 | 212 | 2 | EFO_0006830, EFO_0006896 | |
| Disease | Primary Ciliary Dyskinesia | 4.70e-03 | 47 | 212 | 3 | C4551720 | |
| Disease | cholesteryl ester measurement, intermediate density lipoprotein measurement | 4.77e-03 | 94 | 212 | 4 | EFO_0008595, EFO_0010351 | |
| Disease | Schizophrenia | ABCA1 SPTBN2 GC PLAA HP PLCL2 DNMT1 VIP VPS39 CNTNAP2 ERVK-8 PIP4K2C MDGA1 MYO16 | 4.91e-03 | 883 | 212 | 14 | C0036341 |
| Disease | Osteopenia | 5.07e-03 | 15 | 212 | 2 | C0029453 | |
| Disease | myelodysplastic syndrome (implicated_via_orthology) | 5.07e-03 | 15 | 212 | 2 | DOID:0050908 (implicated_via_orthology) | |
| Disease | head and neck squamous cell carcinoma (is_implicated_in) | 5.07e-03 | 15 | 212 | 2 | DOID:5520 (is_implicated_in) | |
| Disease | lung adenocarcinoma (is_implicated_in) | 5.28e-03 | 49 | 212 | 3 | DOID:3910 (is_implicated_in) | |
| Disease | phospholipids in medium LDL measurement | 5.28e-03 | 49 | 212 | 3 | EFO_0022183 | |
| Disease | cholestasis (biomarker_via_orthology) | 5.28e-03 | 49 | 212 | 3 | DOID:13580 (biomarker_via_orthology) | |
| Disease | cholesterol in medium LDL measurement | 5.28e-03 | 49 | 212 | 3 | EFO_0022224 | |
| Disease | cholesterol in small LDL measurement | 5.28e-03 | 49 | 212 | 3 | EFO_0022227 | |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 5.29e-03 | 220 | 212 | 6 | EFO_0004529, EFO_0008317 | |
| Disease | inflammatory bowel disease | 5.41e-03 | 449 | 212 | 9 | EFO_0003767 | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 5.64e-03 | 157 | 212 | 5 | DOID:224 (biomarker_via_orthology) | |
| Disease | non-high density lipoprotein cholesterol measurement | ABCA1 GC CFB HP DIP2B BEND5 APOB IGF2R ABCA6 USO1 GCC2 DNAH11 | 5.69e-03 | 713 | 212 | 12 | EFO_0005689 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LVQQAKKLKEYGALV | 211 | Q7L4P6 | |
| KKDLVKLQAGEYVSL | 571 | O60488 | |
| YKLLKKASEGLKSIN | 91 | Q8WW43 | |
| LNETTLAALLKKQGY | 116 | P54793 | |
| AQLKKLTQLATKYLE | 51 | P61579 | |
| IGSLKQLTYLDVSKN | 226 | Q96RT1 | |
| LLKYSSQALVVGQKA | 636 | Q9P281 | |
| IGKKFKELNLTNIYA | 671 | Q92667 | |
| NLSYNLIGKIEKLDK | 131 | Q7Z7A1 | |
| ELNLSYNKISKIEGI | 151 | Q7Z7A1 | |
| IQLKKISEAGKDLLY | 481 | Q7Z7A1 | |
| AQLKKLTQLATKYLE | 51 | O71037 | |
| AQLKKLTQLATKYLE | 51 | Q902F8 | |
| AQLKKLTQLATKYLE | 51 | Q9UKH3 | |
| NKALDYIASKGVKLV | 101 | P35609 | |
| GSSYKLLVEQAKLKQ | 2266 | Q9NR09 | |
| SLLINKAGNVYKLTL | 626 | Q9H7T0 | |
| LVKSKQKAYFILSLG | 236 | Q2NKJ3 | |
| EGYLAKVKSLLNKDL | 76 | P26358 | |
| SLIKQKTGIAQLVKY | 1276 | Q9P2K8 | |
| KTGIAQLVKYGLKDL | 1281 | Q9P2K8 | |
| KLTELTQLYKSLQQK | 281 | Q9BWW8 | |
| LSYIKIGKNLLRISK | 236 | Q9UPC5 | |
| KTYVQIIAKSLKNKI | 1511 | O95477 | |
| SIQHLKNKLGKDYIL | 1496 | Q8N139 | |
| ASKQITADKQYKGII | 41 | P05141 | |
| KKRNTILKYIGNLDL | 751 | Q96DT5 | |
| SQLVYQKKLKDALTV | 296 | Q96P50 | |
| NGLKLQTKTIKVSYA | 101 | Q14576 | |
| LLKKKANVNAIDYLG | 171 | Q8N2N9 | |
| SGKSQEIGKLKQLLY | 801 | Q8N283 | |
| KLQESLLKKLGSNTY | 106 | P10523 | |
| DKYGGTSIQLQLKEK | 276 | Q9UBU7 | |
| KKIAQLTKVIYALNT | 46 | Q8NB25 | |
| LNLKKTAIKIQSVYR | 2091 | Q8IZT6 | |
| TSLYGLILNNNKLTK | 126 | Q9BXN1 | |
| IKQAFYGKLSKLQLS | 1436 | Q8IXJ9 | |
| ILNLGAKLYLTNSKQ | 536 | O00203 | |
| LLQKRGVQSYKSKFK | 326 | Q6P387 | |
| FYLGTIKKINILKQS | 61 | Q9Y483 | |
| AQLKKLTQLATKYLE | 51 | P61574 | |
| KKLKNLSEYAQTLQL | 706 | Q8NDT2 | |
| AQLKKLTQLATKYLE | 51 | P61572 | |
| QLKKLTQLATKYLEN | 51 | P61571 | |
| AQLKKLTQLATKYLE | 51 | Q69383 | |
| AQLKKLTQLATKYLE | 51 | P61573 | |
| KTGQEIYKQTKLFLE | 151 | Q9UJ41 | |
| SVISYLKKLSQQAKI | 451 | Q9UL03 | |
| LSKIQLVGYSQKIEL | 191 | Q9NV88 | |
| SKLKKAGNQTGLYVL | 411 | O60674 | |
| LKAQILGYKASVKSL | 521 | O75665 | |
| TVAQIKAGYQSLKKI | 271 | Q9UGN5 | |
| VYKVKLLENTANGTL | 246 | Q9Y5H9 | |
| QSLVKLEKLFLGYNK | 1291 | Q6ZRR7 | |
| KYTLLLGQDENSVIK | 191 | Q9H8H0 | |
| YSQAKDLAKGSIVLK | 646 | Q08J23 | |
| DVALIKLKNKLKYGQ | 576 | P00751 | |
| YTQGETKVLKLKNLR | 191 | Q8NFP4 | |
| KLLKQKRITLGYTQA | 151 | Q06416 | |
| TVQKGISSKKLVDYI | 391 | P32926 | |
| SSVKRKKGNYLLETI | 106 | Q9UBM8 | |
| LSQDDIKGIQKLYGK | 246 | P09237 | |
| SLINLKYLDLGKNQI | 531 | A4D1F6 | |
| QGLYKLKELILSSNK | 106 | O43300 | |
| KLRKGYLFLKISDQQ | 1186 | Q86XX4 | |
| NYSQVDIGLIKLKQK | 241 | P00738 | |
| AQLAKKDYLGKATVV | 191 | P19878 | |
| SIIGENKNYLELSKL | 981 | Q9Y6X6 | |
| SLYEAKIKNLVKGIQ | 566 | Q86W26 | |
| FIGVLYKDKKLNLLT | 391 | P53671 | |
| TYIDKLKTVNLVLKN | 1166 | Q03001 | |
| KYLKLQKLFQSVSAT | 381 | Q8NCI6 | |
| NLKKTIAYSLTKNIA | 786 | P54707 | |
| IKLYGDKSDTIKQVL | 706 | Q8IVV2 | |
| LQLLIKEDYLNKKGN | 1401 | Q5H9U9 | |
| QKKAKYTLNDTGLLG | 1441 | O15031 | |
| SSKKVRVKLGNLELY | 921 | O60486 | |
| KLAEQYAKENGTKLL | 231 | P00480 | |
| KTRLKSQLLLQKYIA | 781 | Q32MK0 | |
| QKSLTGYLEKKRLLF | 1566 | Q96JB1 | |
| KLVKNKLSLEGSSYR | 1881 | O60229 | |
| KAIAQLNSKYGKKVL | 186 | P08473 | |
| LNSKYGKKVLINLFV | 191 | P08473 | |
| ITQKGYEKKRSKLLS | 36 | Q9P265 | |
| DINLNLLKDKGYTTL | 1551 | Q9HD67 | |
| KDYLDQLTQILKVTG | 226 | O15264 | |
| EVLAGLLTNNKKLTY | 741 | Q96MN2 | |
| KEKLLYGLASVKNVT | 816 | Q07075 | |
| GIELITKFLQYESKK | 446 | Q00537 | |
| ILYILFKLSKGKTTA | 111 | Q7Z5B4 | |
| LIYSVKNSEVKGALK | 286 | Q8NG76 | |
| DIGLNSLQKYKLSLN | 161 | Q9Y5G0 | |
| GKQKTVYQTLSAKLL | 771 | Q969R2 | |
| LGNKVKSEVNKLYKL | 1021 | P09884 | |
| EVVYSNKQSLLGKLK | 991 | A8MWY0 | |
| IYTGNAKGKILVLKT | 166 | Q15291 | |
| KLLKQKRITLGYTQA | 151 | Q01860 | |
| KYGLLNVTKIAENGK | 466 | Q8IWW6 | |
| GEVKLSISYKNNKLF | 1506 | O00750 | |
| KSYKALINLVQGKDD | 421 | Q8NB91 | |
| YQQGDLDKALLLTKK | 216 | P13674 | |
| YLKAASQILILKDGK | 596 | O15439 | |
| KLLKSVENLGVSYVK | 51 | P49643 | |
| DLYNGKTTKLQLSKN | 126 | O60884 | |
| KSILGYNLKKSIGQR | 371 | Q99999 | |
| RKTSYLNALKKLQEI | 496 | Q9P2Q2 | |
| GKTSYRLTLDIQNKK | 1086 | P04114 | |
| LQGKILQYKKRCSEL | 176 | Q5TZA2 | |
| SLKSQISALQKGYSK | 301 | B1AJZ9 | |
| LLGTYEKAKQKDQLA | 376 | Q96CN9 | |
| LISLKYSSQKQGLLV | 271 | Q14184 | |
| VKSVLTAAGNLKLKY | 1606 | Q8TD57 | |
| AQLKKLTQLATKYLE | 51 | P61570 | |
| AQLKKLTQLATKYLE | 51 | Q69384 | |
| QLIIKYDLKSNGKFA | 1366 | Q5THR3 | |
| TLGHSKLDLITKYNK | 721 | Q9BQN1 | |
| KQLLARYKGVSKSVI | 801 | Q6P158 | |
| LLDYEKKIKNQTGAS | 291 | Q9BY84 | |
| KELNIKIDSALQAYK | 271 | O15063 | |
| GLKETLKALQVSKYS | 121 | Q6ZRK6 | |
| LKALQVSKYSLQKKV | 126 | Q6ZRK6 | |
| LQILNVSLEDKGSYK | 176 | Q4KMG0 | |
| IKNLQEKNGVYLLSL | 561 | Q8IWJ2 | |
| DKTLKRGYFQKSLVL | 161 | Q8IWF6 | |
| EDILKLYATNKSKLG | 136 | A0A0U1RQE8 | |
| DDKKLALNKLSLNLY | 1001 | Q9BZC7 | |
| QSVVADQLKGLKTYL | 556 | O60503 | |
| NVSKLKKLEYLNLAL | 61 | Q86X45 | |
| QLKKLTQLATKYLEN | 51 | P61565 | |
| FKSIIKQESVLGLYK | 46 | Q8N8R3 | |
| KVLENYNKGKTALLS | 661 | Q9Y4D2 | |
| KKKQTNYLRTLINEL | 4441 | Q14204 | |
| KSSALFYQKLIEKNG | 491 | Q9UEF7 | |
| QQGDYITLELKKAKL | 231 | Q9UHC6 | |
| AQLKKLTQLATKYLE | 51 | Q902F9 | |
| LSKKTLKGLQEAQYR | 76 | Q13206 | |
| KKALKAINSLGYLTS | 3286 | Q8NDH2 | |
| SLEKYKGKVSLVVNV | 61 | Q8TED1 | |
| NKLIGSIVLTKYNNK | 316 | Q7Z3Z3 | |
| LVAGNYLIVITKKIK | 66 | Q9NTJ5 | |
| KQKVYNSKTGIDQLV | 861 | Q14562 | |
| KKFKIEANAGQLYLT | 556 | O43395 | |
| KQLSSTVFKYKLIGI | 561 | Q9BXW9 | |
| TGQEYAAKIINTKKL | 36 | Q13557 | |
| YLSSKLKQLLQTQDK | 686 | Q13029 | |
| LDKGILKYAKSQTDI | 76 | Q9H4L5 | |
| ITLVNLKKDAKYGLG | 1091 | Q12923 | |
| FIKGKYKSALQVLIE | 176 | Q8WV60 | |
| GLIDILTQYDAKKKA | 371 | Q8TBX8 | |
| LEISYAKGLQKLASK | 41 | Q8IVI9 | |
| SLLGKKGNLEKLQSY | 461 | Q99683 | |
| KELIGLVVLTKYNNK | 301 | Q96J94 | |
| GLLTQKLTYENGLLK | 1296 | P11717 | |
| KLVGSVKALQKQYVS | 21 | Q9Y4G2 | |
| SKNIYLNVAVNTLKK | 856 | Q8N1G1 | |
| LKSLSKKYRLEVGIQ | 46 | O60763 | |
| KDKLTKSLTYILGNQ | 271 | Q7Z4K8 | |
| SYSQKIQEAVKALKL | 1091 | O95602 | |
| SINKKLGLLSYKDRI | 1151 | O60522 | |
| KILKKGIYVDAVNSL | 41 | Q8IWB6 | |
| LIYKKKTRLLKASNG | 401 | Q8N9U0 | |
| YLIKDGKLIKNNAST | 291 | P39023 | |
| NDIGQKIYSKIKSVL | 236 | Q9H6L5 | |
| EKLNDKVGLKTVLSY | 241 | Q9UPU3 | |
| ILKGQADLLKYAKNE | 1066 | Q9UPR0 | |
| IKLQTSQGKTREKLY | 851 | Q92835 | |
| TLKYGNLKEKKALFL | 241 | P61647 | |
| KLGQLLYLTNLEKSQ | 1406 | Q149N8 | |
| AYILNLVKQIKKTGC | 281 | P50991 | |
| GNKKAQLKIYTRLAT | 1271 | Q8TE82 | |
| LKNGVILSKLVNSLY | 56 | Q01995 | |
| LLKQSGQKKSYTLRV | 161 | Q9P2P6 | |
| GQEYAAKIINTKKLS | 36 | Q9UQM7 | |
| LTIESLYKNLRKANK | 646 | Q5T5J6 | |
| IDVSYSNIKNGLVKL | 446 | O94855 | |
| LTKLVLVNAIYFKGK | 156 | P50452 | |
| ASKQISAEKQYKGII | 41 | P12235 | |
| KTTILYKLKLGQSVT | 26 | P62330 | |
| KGLLKALKVLDNYLT | 131 | O00299 | |
| LSVLYKGEAKVVLLK | 6 | O15498 | |
| VQLKDLILADYGKKN | 1981 | Q6P2Q9 | |
| TLKAYQEGRLQKLLK | 136 | Q16881 | |
| KLKGKLRSLENQLYT | 241 | Q9Y228 | |
| LLTSGKYDLKKQRSV | 1381 | A0JNW5 | |
| NGVSLLKQIYKTTKN | 461 | Q8IWX7 | |
| NGKYILTATLDNTLK | 221 | Q86VZ2 | |
| KLNTSAGNVDIYKKL | 211 | O15393 | |
| SKSYIILQLEQGKEL | 51 | Q6ZN79 | |
| TQKVLDLKINLKASY | 641 | Q96RL7 | |
| VDLYQSLQKLLADKK | 156 | Q99797 | |
| LKYQIDKLIKTAVTG | 106 | Q8NEJ9 | |
| YGKDLTSVNILLKKQ | 1411 | O15020 | |
| KDLNAYKKQGIALLT | 206 | Q5VWJ9 | |
| KGIKLLQAQKLVQYL | 141 | Q13813 | |
| RLNYLKNGVLKSALK | 341 | O75063 | |
| RKLLSSLQYNKNLLK | 61 | Q5SVQ8 | |
| QLAKSLGVDSQIKKY | 761 | Q9Y263 | |
| SSVLSIKQKGKRELY | 2131 | Q9H5I5 | |
| GKVYDLKNQIILKLS | 211 | Q9C0C9 | |
| YGEKKSRLSNLIKLA | 226 | P02774 | |
| AQYFKKVLGDTLLTK | 426 | P19174 | |
| AKKQLSKDSILSLYG | 296 | Q8IYB5 | |
| ETQDIYQKLLGKLQT | 1021 | Q70Z35 | |
| YQKLLGKLQTALKEV | 1026 | Q70Z35 | |
| LSLYDNKLQTIAKGT | 401 | O94813 | |
| AQLKKLTQLATKYLE | 51 | P61575 | |
| SKSYIILQLEQGKEL | 51 | A8MWA4 | |
| AGQKLSIYNALKKDL | 3171 | Q15149 | |
| LTILSKKKNGNYCVL | 351 | P31939 | |
| SKSYIILQLEQGKEL | 51 | A8MUZ8 | |
| QKKISSKINYSVLRG | 531 | Q92994 | |
| YLSLKEAQLISKQKQ | 561 | O14512 | |
| AKKLGYKFLESLLQK | 141 | Q9P2E3 | |
| SVLKYEKIKGVSSNL | 1096 | Q9P2E3 | |
| EYLKKGSEQQLSQKV | 96 | Q96MM3 | |
| VSELVISKINYLGKK | 151 | Q06730 | |
| SKSYIILQLEQGKEL | 51 | P0CI00 | |
| SKSYIILQLEQGKEL | 51 | P0CH99 | |
| NEKQLYGSSNTLLKK | 441 | Q9UJ78 | |
| IYLSKLGNVETGKKN | 226 | Q6NX49 | |
| VLSLALKGLYKTLKA | 2351 | O43149 | |
| KKSTLSLYQKIQGEG | 666 | Q9Y2H8 | |
| TKGYIKSQEDAKLLI | 746 | Q5TAH2 | |
| LLSLGSNGYKKLLKE | 326 | Q9HD40 | |
| NKVLTIAAKIKGQAY | 1001 | Q13395 | |
| TYEKLNDKVGLKTIL | 216 | Q8WY21 | |
| DIGLLKLKQELKYSN | 206 | Q9UI38 | |
| IIKGLSYLQLKNTKQ | 411 | Q69YN4 | |
| SKLLGQLSAKKYLES | 91 | P01282 | |
| LKIGELQKLYSKADS | 1086 | O60293 | |
| LQKLYSKADSLKQLI | 1091 | O60293 | |
| LTNKQYELLSKNLRK | 556 | Q08AF3 | |
| LKKASKEIYQLRGQS | 1046 | Q9ULE0 | |
| YQGLVVKQLVSQSKK | 731 | O94874 | |
| LKVNGLKAKKLSLYQ | 411 | A6NCI4 | |
| QLVKNEKGTIKQAYT | 1606 | Q5T200 | |
| LYSSKQILKQKLLLA | 2776 | O95071 | |
| LIDYLTQKRSQLVKK | 416 | Q96JC1 | |
| NSQKLQILYKSLEKS | 6 | Q8WU03 | |
| KVGSNKAYLGLSLKQ | 741 | Q96L42 | |
| TQISKIISNAEYKKG | 186 | O76041 |